{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:41:48Z","timestamp":1788864108994,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Natural Science Foundation grant","award":["7252053"],"award-info":[{"award-number":["7252053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00408-025-00807-5","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T01:04:12Z","timestamp":1742432652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic Patients"],"prefix":"10.1007","volume":"203","author":[{"given":"Fangping","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"807_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.lpm.2016.02.017","volume":"45","author":"T Th\u00e9venot","year":"2016","unstructured":"Th\u00e9venot T, Weil D, Garioud A, Lison H, Cadranel JF, Degano B (2016) Hepatopulmonary syndrome. Presse Med 45:509\u2013514. https:\/\/doi.org\/10.1016\/j.lpm.2016.02.017","journal-title":"Presse Med"},{"key":"807_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65204","volume":"16","author":"A Qasim","year":"2024","unstructured":"Qasim A, Jyala A, Shrivastava S, Allena N, Ghazanfar H, Bhatt V, Ali HR, Vakde T, Patel H (2024) Hepatopulmonary syndrome: a comprehensive review. Cureus 16:e65204. https:\/\/doi.org\/10.7759\/cureus.65204","journal-title":"Cureus"},{"key":"807_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/hep.0000000000000605","volume":"79","author":"X Zhao","year":"2024","unstructured":"Zhao X, Kotha S, Nayyar D, Ma X, Lilly L, Castel H, Gupta S (2024) Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: a longitudinal and predictor analysis. Hepatology 79:636\u2013649. https:\/\/doi.org\/10.1097\/hep.0000000000000605","journal-title":"Hepatology"},{"key":"807_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/670139","volume":"2013","author":"A Eshraghian","year":"2013","unstructured":"Eshraghian A, Kamyab AA, Yoon SK (2013) Pharmacological treatment for hepatopulmonary syndrome. Biomed Res Int 2013:670139. https:\/\/doi.org\/10.1155\/2013\/670139","journal-title":"Biomed Res Int"},{"key":"807_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MOG.0000000000000067","volume":"30","author":"DG Koch","year":"2014","unstructured":"Koch DG, Fallon MB (2014) Hepatopulmonary syndrome. Curr Opin Gastroenterol 30:260\u2013264. https:\/\/doi.org\/10.1097\/MOG.0000000000000067","journal-title":"Curr Opin Gastroenterol"},{"key":"807_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrgastro.2012.123","volume":"9","author":"J Zhang","year":"2012","unstructured":"Zhang J, Fallon MB (2012) Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol 9:539\u2013549. https:\/\/doi.org\/10.1038\/nrgastro.2012.123","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"807_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/cs20140622","volume":"129","author":"CC Chang","year":"2015","unstructured":"Chang CC, Wang SS, Hsieh HG, Lee WS, Chuang CL, Lin HC, Lee FY, Lee SD, Huang HC (2015) Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung. Clin Sci (Lond) 129:449\u2013460. https:\/\/doi.org\/10.1042\/cs20140622","journal-title":"Clin Sci (Lond)"},{"key":"807_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2008.12.001","volume":"136","author":"J Zhang","year":"2009","unstructured":"Zhang J, Luo B, Tang L, Wang Y, Stockard CR, Kadish I, Van Groen T, Grizzle WE, Ponnazhagan S, Fallon MB (2009) Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 136:1070\u20131080. https:\/\/doi.org\/10.1053\/j.gastro.2008.12.001","journal-title":"Gastroenterology"},{"key":"807_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/hep.20244","volume":"39","author":"Y Ling","year":"2004","unstructured":"Ling Y, Zhang J, Luo B, Song D, Liu L, Tang L, Stockard CR, Grizzle WE, Ku DD, Fallon MB (2004) The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology 39:1593\u20131602. https:\/\/doi.org\/10.1002\/hep.20244","journal-title":"Hepatology"},{"key":"807_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ajpath.2014.02.027","volume":"184","author":"J Zhang","year":"2014","unstructured":"Zhang J, Yang W, Hu B, Wu W, Fallon MB (2014) Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome. Am J Pathol 184:1706\u20131714. https:\/\/doi.org\/10.1016\/j.ajpath.2014.02.027","journal-title":"Am J Pathol"},{"key":"807_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2023.03.018","volume":"79","author":"S Baweja","year":"2023","unstructured":"Baweja S, Kumari A, Negi P, Tomar A, Tripathi DM, Mourya AK, Rastogi A, Subudhi PD, Thangariyal S, Kumar G, Kumar J, Reddy GS, Sood AK, Vashistha C, Sarohi V, Bihari C, Maiwall R, Sarin SK (2023) Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. J Hepatol 79:167\u2013180. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.018","journal-title":"J Hepatol"},{"key":"807_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1164\/rccm.202307-1289OC","volume":"210","author":"F Robert","year":"2024","unstructured":"Robert F, Certain MC, Baron A, Thuillet R, Duhaut L, Ottaviani M, Chelgham MK, Normand C, Berrebeh N, Ricard N, Furlan V, Desroches-Castan A, Gonzales E, Jacquemin E, Sitbon O, Humbert M, Bailly S, Coilly A, Guignabert C, Tu L, Savale L (2024) Disrupted BMP-9 signaling impairs pulmonary vascular integrity in hepatopulmonary syndrome. Am J Respir Crit Care Med 210:648\u2013661. https:\/\/doi.org\/10.1164\/rccm.202307-1289OC","journal-title":"Am J Respir Crit Care Med"},{"key":"807_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03081-y","author":"F Ding","year":"2024","unstructured":"Ding F, Wang Z, Wang J, Ma Y, Jin J (2024) Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function. BMC Pulm Med. https:\/\/doi.org\/10.1186\/s12890-024-03081-y","journal-title":"BMC Pulm Med"},{"key":"807_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bph.15285","volume":"178","author":"Q Jiang","year":"2021","unstructured":"Jiang Q, Liu C, Liu S, Lu W, Li Y, Luo X, Ma R, Zhang C, Chen H, Chen Y, Zhang Z, Hong C, Guo W, Wang T, Yang K, Wang J (2021) Dysregulation of BMP9\/BMPR2\/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats. Br J Pharmacol 178:203\u2013216. https:\/\/doi.org\/10.1111\/bph.15285","journal-title":"Br J Pharmacol"},{"key":"807_CR15","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1164\/rccm.202109-2174OC","volume":"207","author":"T Yanagihara","year":"2023","unstructured":"Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, Schupp JC, Sato S, Scallan C, Upagupta C, Revill S, Ayoub A, Chong SG, Dvorkin-Gheva A, Kaminski N, Tikkanen J, Keshavjee S, Par\u00e9 G, Guignabert C, Ask K, Kolb MRJ (2023) Vascular-parenchymal cross-talk promotes lung fibrosis through bmpr2 signaling. Am J Respir Crit Care Med 207:1498\u20131514. https:\/\/doi.org\/10.1164\/rccm.202109-2174OC","journal-title":"Am J Respir Crit Care Med"},{"key":"807_CR16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1164\/rccm.201401-0121OC","volume":"190","author":"J Chen","year":"2014","unstructured":"Chen J, Tang H, Sysol JR, Moreno-Vinasco L, Shioura KM, Chen T, Gorshkova I, Wang L, Huang LS, Usatyuk PV, Sammani S, Zhou G, Raj JU, Garcia JG, Berdyshev E, Yuan JX, Natarajan V, Machado RF (2014) The sphingosine kinase 1\/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. Am J Respir Crit Care Med 190:1032\u20131043. https:\/\/doi.org\/10.1164\/rccm.201401-0121OC","journal-title":"Am J Respir Crit Care Med"},{"key":"807_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","volume":"199","author":"I Nikolic","year":"2019","unstructured":"Nikolic I, Yung LM, Yang P, Malhotra R, Paskin-Flerlage SD, Dinter T, Bocobo GA, Tumelty KE, Faugno AJ, Troncone L, McNeil ME, Huang X, Coser KR, Lai CSC, Upton PD, Goumans MJ, Zamanian RT, Elliott CG, Lee A, Zheng W, Berasi SP, Huard C, Morrell NW, Chung RT, Channick RW, Roberts KE, Yu PB (2019) Bone morphogenetic protein 9 Is a mechanistic biomarker of portopulmonary hypertension. Am J Respir Crit Care Med 199:891\u2013902. https:\/\/doi.org\/10.1164\/rccm.201807-1236OC","journal-title":"Am J Respir Crit Care Med"},{"key":"807_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/bj20051524","volume":"396","author":"A Tsuji","year":"2006","unstructured":"Tsuji A, Kikuchi Y, Sato Y, Koide S, Yuasa K, Nagahama M, Matsuda Y (2006) A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4. Biochem J 396:51\u201359. https:\/\/doi.org\/10.1042\/bj20051524","journal-title":"Biochem J"},{"key":"807_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1165\/rcmb.2015-0036OC","volume":"54","author":"J Jin","year":"2016","unstructured":"Jin J, Li Y, Ren J, Man Lam S, Zhang Y, Hou Y, Zhang X, Xu R, Shui G, Ma RZ (2016) Neonatal respiratory failure with retarded perinatal lung maturation in mice caused by reticulocalbin 3 disruption. Am J Respir Cell Mol Biol 54:410\u2013423. https:\/\/doi.org\/10.1165\/rcmb.2015-0036OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"807_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1165\/rcmb.2017-0347OC","volume":"59","author":"J Jin","year":"2018","unstructured":"Jin J, Shi X, Li Y, Zhang Q, Guo Y, Li C, Tan P, Fang Q, Ma Y, Ma RZ (2018) Reticulocalbin 3 deficiency in alveolar epithelium exacerbated bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 59:320\u2013333. https:\/\/doi.org\/10.1165\/rcmb.2017-0347OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"807_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12890-023-02360-4","volume":"23","author":"F Ding","year":"2023","unstructured":"Ding F, Yang L, Wang Y, Wang J, Ma Y, Jin J (2023) Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function. BMC Pulm Med 23:68. https:\/\/doi.org\/10.1186\/s12890-023-02360-4","journal-title":"BMC Pulm Med"},{"key":"807_CR22","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00526.2020","author":"X Shi","year":"2021","unstructured":"Shi X, An X, Yang L, Wu Z, Zan D, Li Z, Pang B, Chen Y, Li J, Tan P, Ma RZ, Fang Q, Ma Y, Jin J (2021) Reticulocalbin 3 deficiency in alveolar epithelium attenuated LPS-induced ALI via NF\u03baB signaling. Am J Physiol Lung Cell Mol Physiol. https:\/\/doi.org\/10.1152\/ajplung.00526.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"807_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12931-023-02533-z","volume":"24","author":"M Wu","year":"2023","unstructured":"Wu M, Wang Z, Shi X, Zan D, Chen H, Yang S, Ding F, Yang L, Tan P, Ma RZ, Wang J, Ma L, Ma Y, Jin J (2023) TGFbeta1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation. Respir Res 24:222. https:\/\/doi.org\/10.1186\/s12931-023-02533-z","journal-title":"Respir Res"},{"key":"807_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02304-2021","author":"SM Kawut","year":"2022","unstructured":"Kawut SM, Krowka MJ, Forde KA, Al-Naamani N, Krok KL, Patel M, Bartoli CR, Doyle M, Moutchia J, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB (2022) Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02304-2021","journal-title":"Eur Respir J"},{"key":"807_CR25","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.14218\/jcth.2022.00421","volume":"11","author":"YJ Li","year":"2023","unstructured":"Li YJ, Wu XF, Wang DD, Li P, Liang H, Hu XY, Gan JQ, Sun YZ, Li JH, Li J, Shu X, Song AL, Yang CY, Yang ZY, Yu WF, Yang LQ, Wang XB, Belguise K, Xia ZY, Yi B (2023) Serum soluble vascular endothelial growth factor receptor 1 as a potential biomarker of hepatopulmonary syndrome. J Clin Transl Hepatol 11:1150\u20131160. https:\/\/doi.org\/10.14218\/jcth.2022.00421","journal-title":"J Clin Transl Hepatol"},{"key":"807_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel S, Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397\u2013407. https:\/\/doi.org\/10.1038\/nrm1103","journal-title":"Nat Rev Mol Cell Biol"},{"key":"807_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5551","author":"A Cartier","year":"2019","unstructured":"Cartier A, Hla T (2019) Sphingosine 1-phosphate: lipid signaling in pathology and therapy. Science. https:\/\/doi.org\/10.1126\/science.aar5551","journal-title":"Science"},{"key":"807_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.018","author":"S Baweja","year":"2023","unstructured":"Baweja S, Kumari A, Negi P, Tomar A, Tripathi DM, Mourya AK, Rastogi A, Subudhi PD, Thangariyal S, Kumar G, Kumar J, Reddy GS, Sood AK, Vashistha C, Sarohi V, Bihari C, Maiwall R, Sarin SK (2023) Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.018","journal-title":"J Hepatol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-025-00807-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:42:51Z","timestamp":1766378571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-025-00807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s00408-025-00807-5","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Beijing Youan Hospital (LL-2022\u2013141-K), Beijing Chao-Yang Hospital (2021-KE-295), and carried out in accordance with relevant guidelines and regulations, and written informed consent was obtained from all subjects. This study was registered in the ClinicalTrials.gov database under the identifier NCT05932927.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The patients and the public were not involved in any way.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and Public Involvement"}}],"article-number":"50"}}